- Home
- TOMZ vs LGVN Comparison
TOMZ vs LGVN Comparison
Compare TOMZ & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- LGVN
- Stock Information
- Founded
- TOMZ 1979
- LGVN 2014
- Country
- TOMZ United States
- LGVN United States
- Employees
- TOMZ N/A
- LGVN N/A
- Industry
- TOMZ Diversified Commercial Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- TOMZ Finance
- LGVN Health Care
- Exchange
- TOMZ Nasdaq
- LGVN Nasdaq
- Market Cap
- TOMZ 22.6M
- LGVN 23.4M
- IPO Year
- TOMZ N/A
- LGVN 2021
- Fundamental
- Price
- TOMZ $1.05
- LGVN $1.30
- Analyst Decision
- TOMZ Strong Buy
- LGVN Strong Buy
- Analyst Count
- TOMZ 1
- LGVN 3
- Target Price
- TOMZ $3.50
- LGVN $8.67
- AVG Volume (30 Days)
- TOMZ 21.7K
- LGVN 150.1K
- Earning Date
- TOMZ 07-31-2025
- LGVN 08-13-2025
- Dividend Yield
- TOMZ N/A
- LGVN N/A
- EPS Growth
- TOMZ N/A
- LGVN N/A
- EPS
- TOMZ N/A
- LGVN N/A
- Revenue
- TOMZ $8,201,313.00
- LGVN $2,225,000.00
- Revenue This Year
- TOMZ $3.66
- LGVN N/A
- Revenue Next Year
- TOMZ $139.63
- LGVN $51.48
- P/E Ratio
- TOMZ N/A
- LGVN N/A
- Revenue Growth
- TOMZ 19.09
- LGVN 127.50
- 52 Week Low
- TOMZ $0.60
- LGVN $1.14
- 52 Week High
- TOMZ $1.50
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- TOMZ 53.72
- LGVN 50.50
- Support Level
- TOMZ $1.01
- LGVN $1.15
- Resistance Level
- TOMZ $1.12
- LGVN $1.40
- Average True Range (ATR)
- TOMZ 0.05
- LGVN 0.09
- MACD
- TOMZ -0.01
- LGVN 0.01
- Stochastic Oscillator
- TOMZ 35.71
- LGVN 46.87
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.